Live from the NIH registry
Studies recruiting near Fort Worth right now
Top 25 of 623 recruiting studies, sorted by proximity — each links to its official registry page
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Cook Children's Health Care System — Fort Worth, Texas (4.2 mi)
· Sponsor: The Society for Pediatric Anesthesia
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Cook Children's Health Care System — Fort Worth, Texas (4.2 mi)
· Sponsor: Takeda
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10301, Fort Worth, TX — Fort Worth, Texas (4.2 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
JPS Health Network — Fort Worth, Texas (4.2 mi)
· Sponsor: Hoffmann-La Roche
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
GI Alliance Southlake — Southlake, Texas (16.6 mi)
· Sponsor: Janssen Research & Development, LLC
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Fort Worth, Texas (4.2 mi)
· Sponsor: Ambros Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Heritage Rheumatology and Arthritis Care — Colleyville, Texas (13.1 mi)
· Sponsor: University of Alabama at Birmingham
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: NRG Oncology
Targeting Endoplasmic Reticulum Stress in Human Hypertension
Hypertension
Phase 1, Phase 2
Interventional 70 participants sought
University of North Texas Health Science Center — Fort Worth, Texas (4.2 mi)
· Sponsor: University of North Texas Health Science Center
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Fort Worth, Texas (4.2 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50673 — Fort Worth, Texas (4.2 mi)
· Sponsor: UCB Biopharma SRL
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
Texas Oncology - DFW ( Site 8004) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
NEXT Oncology Dallas — Irving, Texas (23.3 mi)
· Sponsor: Astellas Pharma Inc
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Carrollton regional Medical Center — Carrollton, Texas (29.1 mi)
· Sponsor: Elute, Inc.
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Gastric Adenocarcinoma, Gastric Cancer
Phase 2
Interventional 146 participants sought
Texas Oncology Fort Worth Cancer Center — Fort Worth, Texas (4.2 mi)
· Sponsor: Toray Industries, Inc
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Fort Worth, Texas (4.2 mi)
· Sponsor: AstraZeneca
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Flower Mound, Texas (21.7 mi)
· Sponsor: AstraZeneca
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
Texas Oncology - DFW ( Site 8000) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Helios Clinical Research - WEA — Weatherford, Texas (26.2 mi)
· Sponsor: Pfizer
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
North Hills Medical Research Inc — Bedford, Texas (12.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
JPS Oncology and Infusion Center ( Site 0083) — Fort Worth, Texas (4.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Texas Southwestern Simmons Cancer Center - Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: Pfizer
A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
Advanced-stage Solid Tumors
Phase 1
Interventional 360 participants sought
NEXT Oncology — Irving, Texas (23.3 mi)
· Sponsor: Janssen Research & Development, LLC
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (4.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group